Scinovex
article Open AccessTop 1% cited

Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB

Molecular Cell · 2006 · Vol. 22(2) · pp. 159–168
Dos D. SarbassovSiraj M. AliShomit SenguptaJoon-Ho SheenPeggy P. HsuAlex F. BagleyAndrew L. MarkhardDavid M. Sabatini
PI3K/AKT/mTOR signaling in cancerProtein Kinase Regulation and GTPase SignalingMetabolism, Diabetes, and CancermTORC2BiologyProtein kinase BPI3K/AKT/mTOR pathwayCell biologymTORC1Cancer researchPhosphorylationSignal transduction

MeSH terms

AnimalsAntibiotics, AntineoplasticCell LineCell SurvivalHeLa CellsHumansImmunohistochemistryMaleMice, NudeNeoplasm TransplantationPhosphorylationPrecipitin TestsRetroviridaeTime FactorsTranscription Factors

Funding

  • Howard Hughes Medical Institute
  • W. M. Keck Foundation
  • Rita Allen Foundation
  • Allen Foundation
  • National Institutes of Health
Citations
2,633
FWCI
51.85
field-weighted impact
References
49
Percentile
100%
vs. same field & year
Citations per year
Citation Network

How this paper connects to the literature. Drag to explore, click any node to open that paper.

Prolonged Rapamycin Treatment Inhibits mTORC2 Assembly and Akt/PKB · Scinovex